CDC Updates RSV Vaccine Guidance for Older Adults

New recommendations prioritize RSV vaccinations for those 75 and older, with conditional advice for high-risk individuals aged 60 to 74.

The CDC now strongly recommends RSV vaccinations for all adults aged 75 and older.
Adults aged 60 to 74 should receive the vaccine only if they have high-risk conditions.
The decision follows concerns over vaccine efficacy and potential side effects like Guillain-Barre syndrome.
Moderna, GSK, and Pfizer see varied impacts on market share and stock performance following the updated guidance.
The CDC's updated guidelines aim to simplify vaccination decisions for healthcare providers and patients.